National Institute for Biological Standards and Control (NIBSC), a centre of the Medicine and Healthcare Products Regulatory Agency (MHRA), United Kingdom

The National Institute for Biological Standards and Control (NIBSC) is operating at the interface between cutting edge scientific research, biopharmaceutical quality control (QC) and government regulation, and has recently merged with MHRA (UK National Regulatory Authority) in 2013.  It is the global leader in the field of biological standardisation, responsible for developing and producing over 90% of the International Standards in use around the world to assure the quality of biological medicines.  The NIBSC also plays an important role as one of the four World Health Organization (WHO) Essential Regulatory Laboratories for influenza vaccines.

The Influenza Resource Centre (IRC) within NIBSC has performed leading edge research in the development of improved candidate viruses for use in vaccine, in the development of novel assays for determining the potency of vaccine, and in pandemic influenza.

NIBSC will be the work package leader of work package (WP) 5 (Networking and Dissemination) and will provide advice in WP 2 (Antigen selection and production) and participate in WP 3 (Mouse immunogenicity studies), WP 4 (Challenge studies).